Buy Day today: Good (67) Broad market participation · no major macro event

Amphastar Pharmaceuticals, Inc. (AMPH)

Healthcare Drug Manufacturers - Specialty & Generic

20.20 $

+1.4% vs. previous close

Closing price · As of: 3. Aug 2026

Amphastar Pharmaceuticals, Inc. (AMPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 171 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Income Statement AMPH
Tick rows to compare them in a chart (up to 4)	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	LTM
Revenue	146	181	178	172	182	189	187	171	174	192	183	171	721
Cost of Revenue	73	72	82	85	87	87	100	85	88	93	97	101	379
Gross Profit	73	108	96	87	95	102	87	85	86	99	86	70	341
Research & Development	17	17	20	14	18	21	18	20	20	22	23	27	92
Selling, General & Administrative	12	13	13	16	13	15	13	16	14	39	16	18	88
Total Operating Expenses	36	36	42	39	40	45	42	48	44	73	50	57	224
Operating Income	37	73	54	48	55	57	45	37	42	25	36	14	117
Interest Expense	3.6	14	9.5	8.6	8.6	6.7	6.4	6.3	6.3	6.3	6.6	6.6	26
Pre-Tax Income	33	63	41	47	50	48	44	31	39	22	32	10	103
Income Tax Expense	6.4	14	4.7	4.1	12	7.3	6.0	5.6	8.3	4.2	7.5	3.6	24
Net Income	26	49	36	43	38	40	38	25	31	17	24	6.4	79
EBITDA	43	91	65	70	73	69	65	52	62	42	55	33	191

LTM = last twelve months (sum of the four most recent quarters).

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings